OppenheimerFunds’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $9.21M | Sell |
104,484
-494,699
| -83% | -$43.6M | 0.01% | 681 |
|
|
2018
Q4 | $42.8M | Sell |
599,183
-233,036
| -28% | -$16.6M | 0.06% | 312 |
|
|
2018
Q3 | $102M | Sell |
832,219
-19,234
| -2% | -$2.36M | 0.12% | 187 |
|
|
2018
Q2 | $83.6M | Buy |
851,453
+16,455
| +2% | +$1.62M | 0.1% | 224 |
|
|
2018
Q1 | $69.2M | Buy |
834,998
+29,751
| +4% | +$2.47M | 0.09% | 253 |
|
|
2017
Q4 | $62.5M | Buy |
805,247
+226,127
| +39% | +$17.5M | 0.08% | 268 |
|
|
2017
Q3 | $35.5M | Sell |
579,120
-310
| -0.1% | -$19K | 0.04% | 392 |
|
|
2017
Q2 | $26.7M | Buy |
579,430
+84,660
| +17% | +$3.89M | 0.03% | 462 |
|
|
2017
Q1 | $21.4M | Sell |
494,770
-406,768
| -45% | -$17.6M | 0.03% | 558 |
|
|
2016
Q4 | $34.9M | Sell |
901,538
-101,010
| -10% | -$3.91M | 0.04% | 405 |
|
|
2016
Q3 | $50.8M | Buy |
1,002,548
+170,680
| +21% | +$8.64M | 0.06% | 319 |
|
|
2016
Q2 | $37.8M | Buy |
831,868
+309,308
| +59% | +$14.1M | 0.05% | 384 |
|
|
2016
Q1 | $20.7M | Buy |
522,560
+222,222
| +74% | +$8.79M | 0.03% | 555 |
|
|
2015
Q4 | $17M | Buy |
300,338
+34,818
| +13% | +$1.97M | 0.02% | 622 |
|
|
2015
Q3 | $10.6M | Sell |
265,520
-82,260
| -24% | -$3.27M | 0.01% | 707 |
|
|
2015
Q2 | $16.6M | Buy |
347,780
+164,680
| +90% | +$7.87M | 0.02% | 632 |
|
|
2015
Q1 | $7.27M | Buy |
+183,100
| New | +$7.27M | 0.01% | 802 |
|